Table 1.
Subject characteristics
| N male (%) | Age* | Height (cm) | Weight (kg) | BMI (kg/m2) | BSI-18 | Resting PETCO2 (mmHg) | GOLD stages | FEV1/FVC | FEV1, (%Pred) | |
|---|---|---|---|---|---|---|---|---|---|---|
| COPD |
7 (54%) |
67.5 |
171.8 |
80.8 |
27.5 |
6.2 |
37.8 |
III 5 |
58.4 |
46.9 |
| N = 13 |
|
(7.8#) |
(8.8) |
(22.1) |
(7.9) |
(6.1) |
(1.8) |
II 6 |
(22.1) |
(15.8) |
| |
|
(56–86&) |
|
|
|
|
|
I 2 |
|
|
| Healthy |
8 (67%) |
54.8 (4.8) |
172.2 |
77.3 |
25.9 |
2.1 |
40.0 |
|
|
|
| N = 12 | (46–61) | (10.8) | (13.8) | (2.8) | (3.6) | (2.8) |
*P < 0.001 by Mann–Whitney U for difference between healthy and COPD subjects.
#(SD).
&(range).